Canine Arthritis Treatment Sector: Growth Drivers and Challenges
Growth Drivers
-
Growing Incidence of Obesity in Dogs
-
Increasing Awareness among Pet Owners
Challenges
-
Absence of a Permanent Cure for Arthritis
-
Lack of Early Symptoms in Dogs
Canine Arthritis Treatment Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
4.6% |
|
Base Year Market Size (2024) |
USD 2.56 billion |
|
Forecast Year Market Size (2037) |
USD 4.59 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of canine arthritis treatment is evaluated at USD 2.66 billion.
Canine Arthritis Treatment Market size was over USD 2.56 billion in 2024 and is poised to exceed USD 4.59 billion by 2037, growing at over 4.6% CAGR during the forecast period i.e., between 2025-2037.
North America industry is set to dominate majority revenue share by 2037, on the back of high pet population, in the U.S.
The major players in the market are Boehringer Ingelheim USA Corporation, Norbrook Laboratories Limited, American Regent, Inc., Vetoquinol S.A., Ceva Santé Animale, Elanco Animal Health Inc., Hill's Pet Nutrition, Inc., and others.
